The PMP22 deletion, clinically presenting as HNPP, was detected in 15 (10%), and a PMP22 point mutation in three additional patients (one associated with an HNPP phenotype, two with a CMT phenotype (CMT1E)). This evidence concerns the gene PMP22 and hereditary neuropathy with liability to pressure palsies.